Springer Healthcare IME
Springer Healthcare Independent Medical Education (IME) creates expert-led educational programs that build upon the latest research and professional practice guidelines. Our suite of educational programs are designed to bring about meaningful change in physician behavior by increasing diagnostic ability, optimizing treatment regimens, and thereby contributing to improved patient outcomes.
Springer Healthcare IME
AAIC - Is It Too Soon to Use Blood-Based Biomarkers for AD in Primary Care?
By
Springer Healthcare IME
FEATURING
Michelle M. Mielke
By
Springer Healthcare IME
FEATURING
Michelle M. Mielke
Michelle Mielke discusses the current status for blood-based biomarker use in primary care in light of research presented at AAIC24.
This video is part of the Independent Medical Education program entitled "Journey to a New Era for Alzheimer's Disease". The much-anticipated era of disease-modifying therapy for Alzheimer’s disease has at last dawned, promising significant changes in how the condition is perceived and managed.
Guide yourself through this transition with our carefully designed independent Alzheimer’s disease education program, led by world renowned experts and covering the biggest international conferences and disclosures across 2024.
This program is available in English, French, Spanish, Italian, German, Japanese and Simplified Chinese. Register in your preferred language before you start.
To learn more about the full program, visit https://new-era-alzheimers-disease.ime.springerhealthcare.com/.
This activity is supported by an educational grant from Lilly.
This video is part of the Independent Medical Education program entitled "Journey to a New Era for Alzheimer's Disease". The much-anticipated era of disease-modifying therapy for Alzheimer’s disease has at last dawned, promising significant changes in how the condition is perceived and managed.
Guide yourself through this transition with our carefully designed independent Alzheimer’s disease education program, led by world renowned experts and covering the biggest international conferences and disclosures across 2024.
This program is available in English, French, Spanish, Italian, German, Japanese and Simplified Chinese. Register in your preferred language before you start.
To learn more about the full program, visit https://new-era-alzheimers-disease.ime.springerhealthcare.com/.
This activity is supported by an educational grant from Lilly.
Comments 0
Login to view comments.
Click here to Login
